Thousands of Australians battling a debilitating form of multiple sclerosis have been granted a reprieve, as a groundbreaking ...

Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a review found.

Treatment with fenebrutinib in a 2-year open-label extension study led to significantly reduced disease-related inflammatory activity in those with relapsing MS, according to speaker at ECTRIMS ...

In a cohort of Black and Hispanic individuals with relapsing MS, baseline comorbidities had no significant effect on the safety and efficacy of treatment with Ocrevus, according to data presented at ...

A dramatic price plunge has put a world-class therapy within reach, offering new freedom and hope for thousands of ...

OMAHA, Neb. (WOWT/Gray News) - A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis. Seven years ago, Jan Janisch-Hanzlik began ...

Mirla Avila and Susan Payrovi, MDs, explain MS progression, relapse vs. change, and subtle signs that matter even with a ...